Guinea worm disease

Guinea worm disease
Name	Guinea worm disease
Synonyms	Dracunculiasis
Caption	Dracunculus medinensis emerging from a patient's foot.
Field	Tropical medicine, Parasitology
Symptoms	Painful blister, burning sensation, emergence of worm
Complications	Secondary infection, Arthritis, Tetanus
Onset	~1 year after infection
Duration	Weeks to months for worm emergence
Causes	Infection by Dracunculus medinensis
Risks	Drinking contaminated water
Diagnosis	Based on clinical appearance of blister and worm
Prevention	Water filtration, Health education, Case containment
Treatment	Slow extraction of worm, wound care
Medication	Mebendazole, Metronidazole (adjunctive)
Prognosis	Good with proper care; disability from complications
Frequency	13 provisional human cases in 2023
Deaths	Rare, from secondary infections

Guinea worm disease. It is a painful parasitic infection caused by the nematode Dracunculus medinensis. The disease is acquired by drinking water containing tiny crustaceans infected with larval worms. Historically widespread, it is now on the brink of eradication due to a sustained international campaign.

Overview

The condition has been documented since antiquity, with descriptions found in the Ebers Papyrus and by the Greek physician Galen. The life cycle of the parasite was elucidated by Russian scientist Alexei Fedchenko in the 19th century. The global campaign to eliminate the disease was launched in the 1980s by the World Health Organization and has been spearheaded by the Carter Center, founded by former U.S. President Jimmy Carter. This initiative represents one of the most successful public health efforts in modern history, reducing annual cases from millions to a handful.

Cause and transmission

The causative agent is the female Dracunculus medinensis worm. Humans become infected by ingesting water from ponds or shallow wells containing copepods of the genus Cyclops that harbor infective larvae. The larvae are released in the human stomach, penetrate the intestinal wall, and mature into adults in the connective tissue over approximately one year. After mating, the male worm dies, and the gravid female migrates to the subcutaneous tissue, usually in the lower limbs.

Symptoms and diagnosis

Symptoms begin when the female worm induces a painful, burning blister on the skin, often on the foot or ankle. The blister ruptures upon contact with water, exposing the worm's anterior end. Diagnosis is primarily clinical, based on the characteristic appearance of the blister and the emerging worm. The process can be intensely painful and disabling. Common complications include bacterial infection of the wound, which can lead to cellulitis, abscess formation, and septic arthritis. If the worm breaks during extraction, it can cause severe inflammation.

Prevention and control

Prevention focuses on breaking the cycle of transmission. Key strategies include educating communities to avoid drinking untreated water and promoting the use of fine-mesh cloth filters, like those distributed by the Carter Center. Other critical measures include treating water sources with the larvicide temefos (Abate®) to kill copepods and ensuring safe drinking water through well construction. A cornerstone of the eradication program is active surveillance and immediate case containment to prevent contaminated water sources from infecting others.

Treatment and prognosis

There is no curative drug or vaccine. Treatment involves the centuries-old, careful manual extraction of the worm by winding it around a small stick over several days or weeks, a process depicted in the symbol of medicine, the Rod of Asclepius. Adjunctive use of anti-inflammatory medications or anthelmintics like mebendazole may ease extraction. Prognosis is excellent with proper wound care to prevent tetanus or gangrene. However, if complications like joint infection occur, they can result in permanent contracture or lameness.

Epidemiology

Historically, the disease was endemic across a broad belt of sub-Saharan Africa and parts of Asia, including India and Yemen. In the mid-1980s, an estimated 3.5 million cases occurred annually in over 20 countries. As of 2023, transmission is confined to a few remote areas; only 13 provisional human cases were reported, all in Chad, with additional cases in animals in Chad, Mali, Angola, and Cameroon. This dramatic reduction is a direct result of the eradication campaign.

Eradication efforts

The international eradication campaign, coordinated by the World Health Organization and led in the field by the Carter Center in partnership with UNICEF and the Centers for Disease Control and Prevention, began in earnest after the World Health Assembly declared elimination a goal in 1986. Success has relied on community-based interventions, strong surveillance, and political commitment from endemic countries like Ghana and Sudan. A major recent challenge is the discovery of the parasite in animal hosts, particularly dogs in Chad, complicating the final push for certification of eradication by the International Commission for the Certification of Dracunculiasis Eradication.

Category:Neglected tropical diseases Category:Parasitic diseases Category:Eradicated diseases